Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock wave therapy could be new hope for jaw pain sufferers

NCT ID NCT05907239

Symptom relief Sponsor: University of Sao Paulo General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether focused shock wave therapy can reduce pain and improve jaw function in people with temporomandibular disorders (TMD) of muscular origin. One hundred adults with moderate to severe jaw pain for at least 3 months will receive either shock wave therapy or a sham treatment. Researchers will measure pain, jaw movement, and quality of life over 5 weeks of treatment and follow up for 3 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
focused extracorporeal shock wave therapy (device)
What this could lead to
If it works, this could offer a non-drug option for reducing jaw pain and improving jaw movement in people with TMD.
What could go wrong
This is a small, early-stage trial with no phase designation. The treatment may not provide lasting pain relief, and some people may find the shocks uncomfortable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2023

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pain in the temporomandibular region; * Myofascial pain diagnosed with or without limitation of mouth opening based on the Diagnostic Criteria for TMD (DC/TMD); * Myofascial pain associated or not with joint abnormalities; * Presence of moderate to severe pain: Visual Analogue Scale (VAS) \>4; * Duration of TMD pain (temporomandibular musculoskeletal) ≥3 months; * Written granting of the informed consent form to participate in the study Exclusion Criteria: * Abnormality in blood clotting (coagulopathy) or using some type of anticoagulant; * Primary malignant disease (tumors) in the treatment area; * Acute infection of soft tissue or bone; * Systemic infections; * Epilepsy; * Infiltration of corticosteroids at the application site in the last 6 weeks; * Patient at high risk of some type of anesthesia or analgesia when it eventually has to be used; * Polyarthritis; * Polytrauma Local joint infections; * Previous temporomandibular surgical treatments that compromise mastication; * Treatment by physiotherapy, acupuncture before 3 months of performing the procedures * Depression or other mental disorders; * Clinical diagnosis of associated fibromyalgia; * Associated systemic inflammatory rheumatic diseases; * Widespread pain or pain elsewhere that predominates and overlaps with TMD muscle pain; * Inability to understand the treatment protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Extracorporeal shockwave therapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia myofascial pain syndrome temporomandibular joint disorder temporomandibular joint dysfunction syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Extracorporeal shockwave therapy Temporomandibular joint disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of São Paulo General Hospital

    RECRUITING

    São Paulo, São Paulo, 05403-010, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.